Structural and Quantitative Surface N -Glycomic Profiling of Cisplatin-Treated Melanoma Cells with Distinct Metastatic Potential
Journal of Proteome Research · 2026
DOI: 10.1021/acs.jproteome.6c00603 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2026. Verfasst von Siwon Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Innovative Drugs, Graduate School of Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul06974, Republic of Korea. Hauptthemen laut MEDLINE: Cisplatin, Melanoma, Polysaccharides, Glycomics. Die Arbeit nennt 48 Literaturangaben. Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Melanoma is a highly aggressive skin cancer with strong metastatic potential and frequent chemoresistance. Aberrant N-glycosylation plays a critical role in tumor progression and drug resistance; however, cisplatin-induced alterations in melanoma surface N-glycans remain poorly understood. Thus, this study aimed to perform comprehensive structural and quantitative profiling of surface N-glycans in G-361 (low metastatic potential), A375P (moderate), and SK-MEL-28 (high) melanoma cells following cisplatin treatment using LC–MS/MS. A total of 25, 39, and 28 surface N-glycans were identified in untreated G-361, A375P, and SK-MEL-28 cells, respectively, whereas 40, 37, and 40 N-glycans were detected after cisplatin treatment. Absolute quantification revealed a marked increase in total N-glycan abundance in G-361 (3.2 to 8.4 pmol) and A375P (5.7 to 10.9 pmol), whereas SK-MEL-28 maintained homeostasis (3.9 to 4.0 pmol). Surface N-glycans were predominantly high-mannose and complex-type glycans with extensive sialylation and fucosylation. Cisplatin induced distinct cell line-specific remodeling: G-361 accumulated high-mannose glycans with reduced Neu5Gc-containing sialylation; A375P showed increased glycan branching and Neu5Ac-containing sialylation; and SK-MEL-28 maintained a stable glycan distribution but exhibited increased Neu5Gc-containing sialylation. These results demonstrate adaptive N-glycosylation responses to cisplatin in melanoma cells with distinct metastatic potentials and provide a glycomic framework for understanding cisplatin-associated glycan alterations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Global Innovative Drugs, Graduate School of Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul06974, Republic of Korea.
ORCID-Profile: Ha Hyung Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Kim, S., Kim, K., Park, C. S., Moon, C., Eom, D., Lee, S., Lee, J., Park, Y., An, T., & Kim, H. H. (2026). Structural and Quantitative Surface N -Glycomic Profiling of Cisplatin-Treated Melanoma Cells with Distinct Metastatic Potential. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.6c00603
Vancouver
Kim S, Kim K, Park CS, Moon C, Eom D, Lee S, et al. Structural and Quantitative Surface N -Glycomic Profiling of Cisplatin-Treated Melanoma Cells with Distinct Metastatic Potential. Journal of Proteome Research. 2026. doi:10.1021/acs.jproteome.6c00603
BibTeX
@article{Kim2026,
author = {Kim, Siwon and Kim, Kyuran and Park, Chi Soo and Moon, Chulmin and Eom, Daeun and Lee, Seojeong and Lee, Jihyeon and Park, Yejin and An, Taeyong and Kim, Ha Hyung},
title = {Structural and Quantitative Surface N -Glycomic Profiling of Cisplatin-Treated Melanoma Cells with Distinct Metastatic Potential},
journal = {Journal of Proteome Research},
year = {2026},
doi = {10.1021/acs.jproteome.6c00603}
}
EUVIMED